{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:58:44Z","timestamp":1791097124789,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Artemisinin-based combination therapy, currently considered the therapy of choice for uncomplicated <jats:italic>Plasmodium falciparum<\/jats:italic> malaria in endemic countries, may be under threat from newly emerging parasite resistance to the artemisinin family of drugs. Studies in Southeast Asia suggest some patients exhibit an extended parasite clearance time in the three days immediately following treatment with artesunate monotherapy. This phenotype is likely to become a more important trial endpoint in studies of anti-malarial drug efficacy, but currently requires frequent, closely spaced blood sampling in hospitalized study participants, followed by quantitation of parasite density by microscopy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A simple duplex quantitative PCR method was developed in which distinct fluorescent signals are generated from the human and parasite DNA components in each blood sample. The human amplification target in this assay is the <jats:italic>\u03b2 tubulin<\/jats:italic> gene, and the parasite target is the unique methionine tRNA gene (<jats:italic>pgmet<\/jats:italic>), which exhibits perfect sequence identity in all six <jats:italic>Plasmodium<\/jats:italic> species that naturally infect humans. In a small series of malaria cases treated as hospital in-patients, the abundance of <jats:italic>pgmet<\/jats:italic> DNA was estimated relative to the human DNA target in daily peripheral blood samples, and parasite clearance times calculated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The qPCR assay was reproducibly able to replicate parasite density estimates derived from microscopy, but provided additional data by quantification of parasite density 24 hours after the last positive blood film. Robust estimates of parasite clearance times were produced for a series of patients with clinical malaria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Large studies, particularly in Africa where children represent a major proportion of treated cases, will require a simpler blood sample collection regime, and a method capable of high throughput. The duplex qPCR method tested may fulfil these criteria, and should now be evaluated in such field studies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1475-2875-9-312","type":"journal-article","created":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T19:16:10Z","timestamp":1288984570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance"],"prefix":"10.1186","volume":"9","author":[{"given":"Khalid B","family":"Beshir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice C","family":"Eziefula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L","family":"Chiodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer D","family":"Polley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin J","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,5]]},"reference":[{"key":"1394_CR1","volume-title":"Guidelines for the treatment of malaria","author":"WHO","year":"2010","unstructured":"WHO: Guidelines for the treatment of malaria. 2010, World Health Organization, Geneva, ISBN: 9789241547925, Second","edition":"Second"},{"key":"1394_CR2","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1128\/AAC.41.7.1413","volume":"41","author":"NJ White","year":"1997","unstructured":"White NJ: Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother. 1997, 41: 1413-22.","journal-title":"Antimicrob Agents Chemother"},{"key":"1394_CR3","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(98)07367-X","volume":"353","author":"NJ White","year":"1999","unstructured":"White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, Kokwaro G, Ouma J, Hien TT, Molyneux ME, Taylor TE, Newbold CI, Ruebush TK, Danis M, Greenwood BM, Anderson RM, Olliaro P: Averting a malaria disaster. Lancet. 1999, 353: 1965-1967. 10.1016\/S0140-6736(98)07367-X.","journal-title":"Lancet"},{"key":"1394_CR4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4269\/ajtmh.2007.76.641","volume":"76","author":"AP Alker","year":"2007","unstructured":"Alker AP, Lim P, Sem R, Shah NK, Yi P, Bouth DM, Tsuyuoka R, Maguire JD, Fandeur T, Ariey F, Wongsrichanalai C, Meshnick SR: Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am J Trop Med Hyg. 2007, 76: 641-647.","journal-title":"Am J Trop Med Hyg"},{"key":"1394_CR5","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium: Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008, 359: 2619-2620. 10.1056\/NEJMc0805011.","journal-title":"N Engl J Med"},{"key":"1394_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009, 361: 455-467. 10.1056\/NEJMoa0808859.","journal-title":"N Engl J Med"},{"key":"1394_CR7","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1086\/650301","volume":"201","author":"K Stepniewska","year":"2010","unstructured":"Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, D'Alessandro U, Day NP, de Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton PN, Olliaro P, Osorio L, Price RN, Rowland M, Smithuis F, Taylor WR, Nosten F, White NJ: In vivo parasitological measures of artemisinin susceptibility. J Infect Dis. 2010, 201: 570-579. 10.1086\/650301.","journal-title":"J Infect Dis"},{"key":"1394_CR8","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1371\/journal.pctr.0010015","volume":"1","author":"RL Hallett","year":"2006","unstructured":"Hallett RL, Dunyo S, Ord R, Jawara M, Pinder M, Randall A, Alloueche A, Walraven G, Targett GAT, Alexander N, Sutherland CJ: Treatment of malaria in Gambian children with chloroquine plus sulphadoxine-pyrimethamine favours survival and transmission to mosquitoes of multi-drug-resistant Plasmodium falciparum. PLoS Clin Trials. 2006, 1: e15-10.1371\/journal.pctr.0010015.","journal-title":"PLoS Clin Trials"},{"key":"1394_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1475-2875-9-74","volume":"9","author":"NB Gadalla","year":"2010","unstructured":"Gadalla NB, Elzaki SE, Mukhtar E, Warhurst DC, El-Sayed B, Sutherland CJ: Dynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum. Malaria J. 2010, 9: 74-10.1186\/1475-2875-9-74.","journal-title":"Malaria J"},{"key":"1394_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"24","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT Method. Method. 2001, 24: 402-408. 10.1006\/meth.2001.1262.","journal-title":"Method"},{"key":"1394_CR11","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1128\/AAC.00024-09","volume":"53","author":"CJ Sutherland","year":"2009","unstructured":"Sutherland CJ, Fifer H, Pearce RJ, bin Reza F, Nicholas M, Haustein T, Njimgye-Tekumafor NE, Doherty JF, Gothard P, Polley SD, Chiodini PL: Novel pfdhps haplotypes among imported cases of Plasmodium falciparum malaria in the UK. Antimicr Agents Chemother. 2009, 53: 3405-3410. 10.1128\/AAC.00024-09.","journal-title":"Antimicr Agents Chemother"},{"key":"1394_CR12","unstructured":"MapSeq\/pf. (last accessed 03\/11\/2010), [http:\/\/www.sanger.ac.uk\/MapSeq\/]"},{"key":"1394_CR13","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1086\/652240","volume":"201","author":"CJ Sutherland","year":"2010","unstructured":"Sutherland CJ, Tanomsing N, Nolder D, Oguike M, Jennison C, Pukrittayakamee S, Dolecek C, Hien TT, do Ros\u00e1rio VE, Arez AP, Pinto J, Michon P, Escalante AA, Nosten F, Burke M, Lee R, Blaze M, Otto TD, Barnwell JW, Pain A, Williams J, White NJ, Day NP, Snounou G, Lockhart PJ, Chiodini PL, Imwong M, Polley SD: Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. J Infect Dis. 2010, 201: 1544-1550. 10.1086\/652240.","journal-title":"J Infect Dis"},{"key":"1394_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1475-2875-7-139","volume":"7","author":"DJ Padley","year":"2008","unstructured":"Padley DJ, Heath AB, Sutherland C, Chiodini PL, Baylis SA, the Collaborative Study Group: Establishment of the 1st World Health Organization International Standard for Plasmodium falciparum DNA for nucleic acid amplification technique (NAT)-based assays. Malar J. 2008, 7: 139-10.1186\/1475-2875-7-139.","journal-title":"Malar J"},{"key":"1394_CR15","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1086\/503051","volume":"193","author":"JT Bousema","year":"2006","unstructured":"Bousema JT, Schneider P, Gouagna LC, Drakeley CJ, Tostmann A, Houben R, Githure JI, Ord R, Sutherland CJ, Omar SA, Sauerwein RW: Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J Infect Dis. 2006, 193: 1151-1159. 10.1086\/503051.","journal-title":"J Infect Dis"},{"key":"1394_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1126\/science.1155165","volume":"320","author":"NJ White","year":"2008","unstructured":"White NJ: Qinghaosu (artemisinin): the price of success. Science. 2008, 320: 330-334. 10.1126\/science.1155165.","journal-title":"Science"},{"key":"1394_CR17","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1086\/651562","volume":"201","author":"TJ Anderson","year":"2010","unstructured":"Anderson TJ, Nair S, Nkhoma S, Williams JT, Imwong M, Yi P, Socheat D, Das D, Chotivanich K, Day NP, White NJ, Dondorp AM: High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia. J Infect Dis. 2010, 201: 1326-1330. 10.1086\/651562.","journal-title":"J Infect Dis"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-9-312.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T12:26:42Z","timestamp":1630499202000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-9-312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,5]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1394"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-9-312","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,5]]},"assertion":[{"value":"15 July 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"312"}}